Know Cancer

or
forgot password
  • cancer clinical trials in shakopee, MN

  • Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer
    Saint Francis Regional Medical Center
    Shakopee, Minnesota 55379
    Cervical Cancer, Lymphedema, Sexuality and Reproductive Issues
    Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
    Saint Francis Regional Medical Center
    Shakopee, Minnesota 55379
    Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma, Adult Extraskeletal Chondrosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma, Adult Neurofibrosarcoma, Chondrosarcoma, Endometrial Stromal Sarcoma, Mast Cell Sarcoma, Metastatic Adult Malignant Fibrous Histiocytoma of Bone, Ovarian Carcinosarcoma, Ovarian Sarcoma, Recurrent Adult Malignant Fibrous Histiocytoma of Bone, Recurrent Adult Soft Tissue Sarcoma, Small Intestine Leiomyosarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
    Saint Francis Regional Medical Center
    Shakopee, Minnesota 55379
    Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
    Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot be Removed by Surgery
    Saint Francis Regional Medical Center
    Shakopee, Minnesota 55379
    Childhood Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer, Type 1 Papillary Renal Cell Carcinoma, Type 2 Papillary Renal Cell Carcinoma
    Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Leukemia
    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
    Saint Francis Regional Medical Center
    Shakopee, Minnesota 55379
    Colorectal Cancer
    Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
    Saint Francis Cancer Center
    Shakopee, Minnesota 55379
    Anal Cancer
    High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Melanoma (Skin)
    Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Leukemia
    Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Thymoma, Thymic Carcinoma
    Combination Chemotherapy in Treating Patients With Bladder Cancer
    Saint Francis Cancer Center
    Shakopee, Minnesota 55379
    Bladder Cancer
    Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer
    Saint Francis Cancer Center
    Shakopee, Minnesota 55379
    Kidney Cancer
    Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
    Saint Francis Cancer Center
    Shakopee, Minnesota 55379
    Pancreatic Cancer
    Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium
    Saint Francis Cancer Center
    Shakopee, Minnesota 55379
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer
    Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Colorectal Cancer, Metastatic Cancer
    Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery
    Saint Francis Cancer Center
    Shakopee, Minnesota 55379
    Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Adjuvant Radiation Therapy in Treating Patients With Resected Desmoplastic Melanoma
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Melanoma (Skin)
    Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Lymphoma
    Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Lung Cancer
    Esophagectomy in Treating Patients With High-Grade Dysplasia of the Esophagus or Stage I, Stage II, or Stage III Esophageal Cancer
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Esophageal Cancer
    (Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Fatigue, Sleep Disorders, Unspecified Adult Solid Tumor, Protocol Specific
    Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
    Saint Francis Cancer Center
    Shakopee, Minnesota 55379
    Breast Cancer
    Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Breast Cancer
    Everolimus in Treating Patients With Stage IV Melanoma
    Saint Francis Cancer Center
    Shakopee, Minnesota 55379
    Melanoma (Skin)
    Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Esophageal Cancer
    Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Mesothelioma
    Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Lung Cancer
    ABI-007 (Nab-Paclitaxel) and Gemcitabine in Treating Women With Metastatic Breast Cancer
    Saint Francis Cancer Center
    Shakopee, Minnesota 55379
    Breast Cancer
    Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer
    Saint Francis Cancer Center
    Shakopee, Minnesota 55379
    Pancreatic Cancer
    Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer
    Saint Francis Cancer Center
    Shakopee, Minnesota 55379
    Breast Cancer
    Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Lung Cancer
    Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Lymphoma
    Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Lung Cancer
    Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Breast Cancer
    Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
    Saint Francis Regional Medical Center
    Shakopee, Minnesota 55379
    Recurrent Adult Acute Lymphoblastic Leukemia
    Radiation Therapy, Pemetrexed Disodium, and Carboplatin in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Esophageal Cancer
    S0437 Long-Term Follow-Up of Patients Who Were Diagnosed With Prostate Cancer on PCPT
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Prostate Cancer
    Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Breast Cancer, Drug/Agent Toxicity by Tissue/Organ, Unspecified Adult Solid Tumor, Protocol Specific
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Saint Francis Regional Medical Center
    Shakopee, Minnesota 55379
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By Surgery
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Colorectal Cancer
    Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Lymphoma
    Pilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Breast Cancer, Sexual Dysfunction, Sexuality and Reproductive Issues
    Topical Sunscreen in Preventing Skin Rash in Patients Receiving Drugs Such as Erlotinib or Cetuximab for Cancer
    Saint Francis Cancer Center
    Shakopee, Minnesota 55379
    Dermatologic Complications, Unspecified Adult Solid Tumor, Protocol Specific
    Vitamin E in Preventing Peripheral Neuropathy Caused by Chemotherapy in Patients Receiving Chemotherapy for Cancer
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
    Saint Francis Regional Medical Center
    Shakopee, Minnesota 55379
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Breast Cancer
    Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Breast Cancer, Dermatologic Complications, Radiation Toxicity, Skin Reactions Secondary to Radiation Therapy
    Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Melanoma (Skin)
    Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Pancreatic Cancer
    Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Brain and Central Nervous System Tumors
    Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme
    Saint Francis Regional Medical Center
    Shakopee, Minnesota 55379
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Breast Cancer
    Radiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Lung Cancer
    Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Breast Cancer
    Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
    Saint Francis Regional Medical Center
    Shakopee, Minnesota 55379
    Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes
    Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer
    Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
    St. Francis Cancer Center at St. Francis Medical Center
    Shakopee, Minnesota 55379
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer
    Carboplatin and Paclitaxel Combined With Cetuximab and/or Cixutumumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Saint Francis Regional Medical Center
    Shakopee, Minnesota 55379
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer